Chess Depositary Interests 1:1 Us Prohibited Defer

Chess Depositary Interests 1:1 Us Prohibited Defer

ENLDB · AU · Healthcare / Health Information Services

0.031AUD-0.00 (-3.13%)

Price History

Full chart

Market Stats

Previous Close0.032
Open0.032
Day Range0.03 – 0.032
52-Week Range0.034 – 0.45
Volume150.17K
Market Cap26.92M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.25
Dividend Yield0.00%
Beta-0.43
50-Day Avg0.0462
200-Day Avg0.0849

About

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Darren Scotti
  • Headquarters1635 Foxtrail Drive, Loveland, CO, United States, 80538, Australia
  • Websitehttps://enlitic.com

Leadership

  • Mr. Darren ScottiCFO & Company Secretary
  • Mr. Dan KozimorChief Technology Officer
  • Mr. Scott StantonVice President of Sales Operations
  • Mr. Steve RankinChief Strategy Officer

Financials

Income Statement

Currency: USD2023-12-312024-12-312025-12-31
Total Revenue495.92K1.08M3.80M
Growth (%)-+117.55%+251.87%
Gross Profit495.92K1.08M3.80M
Gross Margin100.00%100.00%100.00%
Operating Expense16.05M16.97M17.15M
Operating Income-15.56M-15.89M-13.35M
Operating Margin-3137.17%-1472.69%-351.68%
EBITDA-15.10M-15.09M-12.63M
EBITDA Margin-3045.33%-1398.77%-332.84%
Net Income-15.55M-15.24M-13.37M
Net Income Margin-3135.89%-1412.41%-352.30%
Interest Expense53.15K23038.33K
Interest Expense % of Total Revenue10.72%0.02%1.01%

Balance Sheet

Currency: USD2023-12-312024-12-312025-12-31
Total Assets11.57M14.20M8.96M
Total Liabilities633.43K3.17M4.88M
Total Equity10.94M11.03M4.08M
Cash11.09M7.16M2.57M

Cash Flow

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Financing Cash Flow-23.72M14.45M7.71M
Capital Expenditure04.58K20.92K12.93K
Free Cash Flow--14.88M-15.19M-11.80M

Key Statistics & Ratios

Market Cap26.92M
Enterprise Value28.17M
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.48
Price / Book5.33
EPS-0.25
Book Value-0.0042
Revenue (TTM)3.60M
Gross Profit (TTM)-7.27M
EBITDA-11.23M
Profit Margin0.00%
Operating Margin-334.85%
Return on Equity-349.07%
Return on Assets-67.39%
Shares Outstanding708.32M
Shares Float426.80M
Beta-0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 11, 20261:10